A novel evodiamine amino derivative as a PI3K/AKT signaling pathway modulator that induces apoptosis in small cell lung cancer cells
Author:
Funder
Chongqing Science and Technology Commission
Chongqing Municipal Education Commission
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference32 articles.
1. Natural products for human health: an historical overview of the drug discovery approaches;Bernardini;Nat. Prod. Res.,2018
2. Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms;Chen;Acta Pharm. Sin. B,2019
3. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the pten/pi3k/akt pathway in lung cancer;De Marco;PloS One,2017
4. Pi3k and akt: unfaithful partners in cancer;Faes;Int. J. Mol. Sci.,2015
5. Evodiamine induces g2/m arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in h446 and h1688 human small-cell lung cancer cells;Fang;PloS One,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alkaloid-based modulators of the PI3K/Akt/mTOR pathway for cancer therapy: Understandings from pharmacological point of view;Chemico-Biological Interactions;2024-10
2. EXPLORING COMPARATIVELY THE CYTOTOXICITY OF MILLED AND 3D-PRINTED PMMA-BASED RESINS TO ORAL SQUAMOUS CANCER CELLS - WHAT SIGNALS COULD THE AKT/MTOR PATHWAY SEND US THROUGH ITS DOWNSTREAM EFFECTOR GSK-3?;ROM J ORAL REHABIL;2024
3. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway;Journal of Natural Medicines;2024-02-07
4. Trans-(±)-TTPG-B Attenuates Cell Cycle Progression and Inhibits Cell Proliferation on Cholangiocarcinoma Cells;Molecules;2023-10-30
5. Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship;European Journal of Medicinal Chemistry;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3